Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Memo|January 1, 2019
ASCO 2018 NSCLC highlights-combination therapy is keyGabriele Gamerith, Florian Kocher, Jakob Rudzki, et al.
Oncology Letters|July 4, 2025
Erratum: [Corrigendum] The impact of metformin and salinomycin on transforming growth factor β-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell linesStefan Koeck, Arno Amann, Julia M Huber, et al.
Oncology Letters|April 14, 2016
The impact of metformin and salinomycin on transforming growth factor β-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell linesStefan Koeck, Arno Amann, Julia M Huber, et al.
Oncoimmunology|July 7, 2017
The influence of stromal cells and tumor-microenvironment-derived cytokines and chemokines on CD3<sup>+</sup>CD8<sup>+</sup> tumor infiltrating lymphocyte subpopulationsStefan Koeck, Johan Kern, Marit Zwierzina, et al.
Clinical Lung Cancer|March 19, 2015
Liver Transplantation-Associated Lung Cancer: Comparison of Clinical Parameters and OutcomesFlorian Kocher, Armin Finkenstedt, Michael Fiegl, et al.
Cancers|March 6, 2021
The Epithelial-Mesenchymal Transcription Factor Slug Predicts Survival Benefit of Up-Front Surgery in Head and Neck CancerHerbert Riechelmann, Teresa Bernadette Steinbichler, Susanne Sprung, et al.
Journal of Cancer Research and Clinical Oncology|July 18, 2016
Evaluation of assays for drug efficacy in a three-dimensional model of the lungJulia M Huber, Arno Amann, Stefan Koeck, et al.
Critical Reviews in Oncology/Hematology|July 10, 2020
Systematic review: Soluble immunological biomarkers in advanced non-small-cell lung cancer (NSCLC)Finn Mildner, Sieghart Sopper, Arno Amann, et al.
Cancers|May 14, 2022
Functional Outcomes in Head and Neck Cancer PatientsHerbert Riechelmann, Daniel Dejaco, Teresa Bernadette Steinbichler, et al.
Cancer Biology & Therapy|December 20, 2013
Increase in antibody-dependent cellular cytotoxicity (ADCC) in a patient with advanced colorectal carcinoma carrying a KRAS mutation under lenalidomide therapyGabriele Gamerith, Thomas Auer, Arno Amann, et al.
Pageof 4